Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
ABN, abstract, adjacent, aggressive, Alderman, amenable, atezolizumab, AusBiotech, AusMedtech, BAVENCIO, Black, Boyce, broader, cation, commercialisation, cr, Danish, dba, Denmark, depressed, depression, DoR, DSUR, durvalumab, encouragingly, entitlementswhe, excessively, Fellow, fortheir, gastrointestinal, Graduate, ID, IDMC, Importantly, inside, INSIDER, Insignia, intrusion, Korean, Krone, Leadership, LH, Lis, mainland, matrix, mDoR, Metastic, Milford, Mini, mode, mOS, NYSE, ofderivative, ontheir, opting, oxaliplatin, paragraph, Piper, Polish, possession, precipitously, privacy, QEF, reducingthe, refractory, rested, revocation, robust, Score, sense, sharesentitle, showcased, Spain, spanning, stakeholder, strong, Switzerland, territory, topotecan, TPS, unitary, UPC, urothelial, vulnerable
Removed:
afflicted, alliance, aromatase, AstraZeneca, began, BLA, Chamberlain, concise, epidermal, examination, explanation, factor, finalized, Freehill, Gilead, hinder, Hollingdale, Idera, improving, inclusion, Incyte, Institut, invent, Lynch, Merrill, Nektar, Nomura, nonsteroidal, organisation, partially, peptide, plc, pre, reaching, rebate, Regeneron, Roche, secret, stringent, surfaced, undergone, vaccine, worsen, Wuhan
Filing tables
Filing exhibits
IMMP similar filings
Filing view
External links